Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Fradet

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
International Journal of Cancer|February 8, 1996
Toxicity of ribosome-inactivating proteins-containing immunotoxins to a human bladder carcinoma cell lineM G Battelli, L Polito, A Bolognesi, et al.
Cancer Research|October 1, 1986
Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristicsY Fradet, C Cordon-Cardo, W F Whitmore, et al.
Cytometry|November 1, 1993
Flow and image cytometry for DNA analysis in bladder washings: improved concordance by using internal reference for flowA Chabanas, J J Rambeaud, D Seigneurin, et al.
The Journal of Urology|January 23, 1999
Electromotive drug administration of lidocaine as an alternative anesthesia for transurethral surgeryM A Jewett, L Valiquette, H A Sampson, et al.
Seminars in Surgical Oncology|September 1, 1992
Cell surface differentiation antigens of normal urothelium and bladder tumorsG Dalbagni, V E Reuter, J Sheinfeld, et al.
Cytometry|January 1, 1993
Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus ConferenceL L Wheeless, R A Badalament, R W de Vere White, et al.
International Journal of Cancer|December 15, 1990
Monoclonal antibody against a tumor-associated sialoglycoprotein of superficial papillary bladder tumors and cervical condylomasY Fradet, H LaRue, C Parent-Vaugeois, et al.
Prostate Cancer and Prostatic Diseases|September 3, 2014
An open-label, phase 2 trial of bicalutamide dose escalation from 50 mg to 150 mg in men with CAB and castration resistance. A Canadian Urology Research Consortium StudyL Klotz, D Drachenberg, R Singal, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 1, 1995
The etiology of bladder cancer--are there any new clues or predictors of behavior?T Shirai, Y Fradet, H Huland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrenceC Pfister, L Moore, P Allard, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
International Journal of Cancer|February 8, 1996
Toxicity of ribosome-inactivating proteins-containing immunotoxins to a human bladder carcinoma cell lineM G Battelli, L Polito, A Bolognesi, et al.
Cancer Research|October 1, 1986
Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristicsY Fradet, C Cordon-Cardo, W F Whitmore, et al.
Cytometry|November 1, 1993
Flow and image cytometry for DNA analysis in bladder washings: improved concordance by using internal reference for flowA Chabanas, J J Rambeaud, D Seigneurin, et al.
The Journal of Urology|January 23, 1999
Electromotive drug administration of lidocaine as an alternative anesthesia for transurethral surgeryM A Jewett, L Valiquette, H A Sampson, et al.
Seminars in Surgical Oncology|September 1, 1992
Cell surface differentiation antigens of normal urothelium and bladder tumorsG Dalbagni, V E Reuter, J Sheinfeld, et al.
Cytometry|January 1, 1993
Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus ConferenceL L Wheeless, R A Badalament, R W de Vere White, et al.
International Journal of Cancer|December 15, 1990
Monoclonal antibody against a tumor-associated sialoglycoprotein of superficial papillary bladder tumors and cervical condylomasY Fradet, H LaRue, C Parent-Vaugeois, et al.
Prostate Cancer and Prostatic Diseases|September 3, 2014
An open-label, phase 2 trial of bicalutamide dose escalation from 50 mg to 150 mg in men with CAB and castration resistance. A Canadian Urology Research Consortium StudyL Klotz, D Drachenberg, R Singal, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 1, 1995
The etiology of bladder cancer--are there any new clues or predictors of behavior?T Shirai, Y Fradet, H Huland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrenceC Pfister, L Moore, P Allard, et al.
Pageof 11